Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 31

1.

Lymphocytosis

Excess of normal lymphocytes in the blood or in any effusion. [from MeSH]

MedGen UID:
9834
Concept ID:
C0024282
Disease or Syndrome
2.

Lymphocytosis

A laboratory test result indicating an abnormal increase in the number of lymphocytes in the peripheral blood, effusions, or bone marrow. [from NCI]

MedGen UID:
777042
Concept ID:
C0853698
Finding
3.

Lymphocytosis

Increase in the number or proportion of lymphocytes in the blood. [from HPO]

MedGen UID:
506546
Concept ID:
CN117716
Finding
4.

Error occurred: cannot get document summary

ID:
231390

5.

B-Cell Lymphomas

A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. [from MeSH]

MedGen UID:
86953
Concept ID:
C0079731
Neoplastic Process
6.

Neoplasm

A general term for autonomous tissue growth in which the malignancy status has not been established and for which the transformed cell type has not been specifically identified. [from NCI]

MedGen UID:
10294
Concept ID:
C0027651
Neoplastic Process
7.

Persistent polyclonal B-cell lymphocytosis

Persistent polyclonal B-cell lymphocytosis is an autosomal dominant condition characterized by onset in infancy of splenomegaly and polyclonal expansion of B cells, resulting in peripheral lymphocytosis. Affected individuals also show mild immune dysfunction, including some defective antibody responses and T-cell anergy. There may be a predisposition to the development of B-cell malignancy (summary by Snow et al., 2012). [from OMIM]

MedGen UID:
341117
Concept ID:
C1847973
Disease or Syndrome
8.

Lymphoma

An antiquated term referring to a malignant lymphoma that is diffused and composed of small and large lymphocytes. [from NCI]

MedGen UID:
44223
Concept ID:
C0024299
Neoplastic Process
9.

Syndrome

A set of symptoms or conditions that occur together and suggest the presence of a certain disease or an increased chance of developing the disease. [from NCI]

MedGen UID:
11688
Concept ID:
C0039082
Disease or Syndrome
10.

Hodgkin lymphoma

A typer of lymphoma characterized microscopically by multinucleated Reed-Sternberg cells. [from HPO]

MedGen UID:
776519
Concept ID:
CN167915
Finding
11.

Absence

MedGen UID:
739164
Concept ID:
C1689985
Anatomical Abnormality
12.

Lymphoma

A cancer originating in lymphocytes and presenting as a solid tumor of lymhpoid cells. [from HPO]

MedGen UID:
505322
Concept ID:
CN002422
Finding
13.

Error occurred: cannot get document summary

ID:
431830

14.

Aggressive behavior

MedGen UID:
98408
Concept ID:
C0424323
Finding
15.

Hodgkin lymphoma

An obsolete term referring to Hodgkin lymphma. [from NCI]

MedGen UID:
9283
Concept ID:
C0019829
Neoplastic Process
16.

Adhesion

Pathological processes consisting of the union of the opposing surfaces of a wound. [from MeSH]

MedGen UID:
7891
Concept ID:
C0001511
Pathologic Function
17.

Malignant lymphoma, non-Hodgkin

Any of a large group of cancers of lymphocytes (white blood cells). NHLs can occur at any age and are often marked by lymph nodes that are larger than normal, fever, and weight loss. There are many different types of NHL. These types can be divided into aggressive (fast-growing) and indolent (slow-growing) types, and they can be formed from either B-cells or T-cells. B-cell NHLs include Burkitt lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), diffuse large B-cell lymphoma, follicular lymphoma, immunoblastic large cell lymphoma, precursor B-lymphoblastic lymphoma, and mantle cell lymphoma. T-cell NHLs include mycosis fungoides, anaplastic large cell lymphoma, and precursor T-lymphoblastic lymphoma. Lymphomas that occur after bone marrow or stem cell transplantation are usually B-cell NHLs. Prognosis and treatment depend on the stage and type of disease. [from NCI]

MedGen UID:
6160
Concept ID:
C0024305
Neoplastic Process
18.

Pleocytosis

Presence of greater than normal number of cells in the cerebrospinal fluid [from SNOMED CT]

MedGen UID:
56247
Concept ID:
C0151857
Finding
19.

vessel (polysaccharide)

MedGen UID:
56099
Concept ID:
C0148346
Pharmacologic Substance
20.

Immunoglobulins

there are two types of polypeptide chains responsible for the biological and immunological properties of the different immunoglobulins, the heavy chain and the light chain; they are linked by covalent and non-covalent forces to give a four-chain Y-shaped structure based on pairs of identical heavy and light chains; each chain consists of a variable region and a constant region which are coded for by different genes; some immunoglobulin classes occur as polymers of this basic monomer. [from CRISP]

MedGen UID:
43841
Concept ID:
C0021027
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...